Exelixis, Inc. (EXEL) Posts Q1 EPS Loss of $0.24
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $58.49 +3.01%
EPS Growth %: +14.1%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +14.1%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Exelixis, Inc. (NASDAQ: EXEL) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $35.9 million versus the consensus estimate of $37.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens Reiterates Market Outperform Rating on Exelixis (EXEL)
- RH (RH) Tops Q2 EPS by $2.31
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
